| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |